Literature DB >> 16733715

[Clinical pathways in endocrinology and diabetology].

B Gallwitz1, H Lehnert, H Dittmann, J Honegger, R Teichmann, M Tatagiba, H U Häring.   

Abstract

Endocrinology and diabetology are disciplines with an interdisciplinary approach. Patients with diabetes or endocrine disorders are diagnosed and treated by multiple disciplines both in an outpatient or in-hospital setting. Additional diabetes-specific professions also participate in the care of diabetic patients. The development of clinical pathways and case-management in institutionalized "Diabetes Centers" and "Endocrinology Centers" as platforms of cooperation is one way to improve patient care and to pool resources. In such centers an interdisciplinary decision support within the diagnostic and therapeutic process is important. E. g., interdisciplinary case conferences expediate and intensify the necessary flow of information. This guarantees the implementation of a rational and concerted treatment according to guidelines and finally optimize the clinical pathways in a continuous process improvement.

Entities:  

Mesh:

Year:  2006        PMID: 16733715     DOI: 10.1007/s00108-006-1649-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  3 in total

Review 1.  Cost estimation of thyroid disorders in Germany.

Authors:  George J Kahaly; Markus Dietlein
Journal:  Thyroid       Date:  2002-10       Impact factor: 6.568

Review 2.  [Postmenopausal and steroid-induced osteoporosis guideline-orientated prevention and treatment].

Authors:  J Pfeilschifter
Journal:  Internist (Berl)       Date:  2005-05       Impact factor: 0.743

3.  ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct--a study protocol [ISRCTN08471887].

Authors:  Stefanie Joos; Thomas Rosemann; Marc Heiderhoff; Michel Wensing; Sabine Ludt; Jochen Gensichen; Petra Kaufmann-Kolle; Joachim Szecsenyi
Journal:  BMC Public Health       Date:  2005-10-04       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.